Skip to content

PAVE Collaboratory

  • About Us
    • About PAVE
    • Our People
    • Martin Delaney Collaboratory
    • Job Opportunities
  • Research
    • RF 1: Pediatric Reservoirs
    • RF 2: Control of Rebound
    • RF 3: Eradication
    • RF 4: Assays, Tools
    • Community
  • Collaboratory
    • Research Institutions
    • Cohorts & Biobanks
    • Industry Partners
    • Community Relationships
  • Resources
    • Resource Library
    • Publications
  • News & Events
    • News
    • Events
  • Contact
  • Twitter
RF-1  |  September 12, 2024
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a
Cell —

©2024

About Us     Research     Collaboratory     News     Contact